Lotto 1
Original notice title
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
50 / 100
Risk factors
The large value attracts strong competition, potentially from major pharmaceutical suppliers.
Requirement for multiple certifications (quality, environmental) may be burdensome for smaller entities.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 10000M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 1460 DAY
- Supply of medicinal products, blood derivatives, vaccines, and contrast media
- Dynamic Acquisition System (DPS) for health authorities in Lazio Region and other aggregating entities
Show full summary
This tender is a Dynamic Acquisition System (DPS) for the supply of medicinal products, blood derivatives, vaccines, and contrast media to health authorities in the Lazio Region and other aggregating entities. It is a restricted procedure with a single lot (Lotto 1) valued at €10 billion, covering a 4-year period. The award is based on price, and participation requires professional registration.
Risks
The large value attracts strong competition, potentially from major pharmaceutical suppliers.
Requirement for multiple certifications (quality, environmental) may be burdensome for smaller entities.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Restricted procedure: only invited or pre-qualified tenders can participate
Administrative
- Electronic submission required via STELLA platform (Open portal)
- Italian language for all submissions
Award Criteria
Lot 1
Buyer
Name
Giunta Regionale
Location
Roma, ITA
Buyer profile
Identifier
80143490581
Activity
General public services
Lots (1)
LOT-0001
Lotto 1
Lotto 1 covers the supply of various medicinal products (CPV 33690000). The estimated value is €10 billion. The lot is part of a DPS open for the duration of the system.
EUR 10B
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Selection criteria
Value note
Show original TED data
Original TED description
Lotto 1
Procurement Details
- Publication date
- 20 lip 2025
- Notice type
- Contract notice — standard
- Languages
- Italian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 473572-2025
Documents (2)
Similar tenders
Spain – Microelectronic machinery and apparatus – Suministro e instalación de un equipo de litografía óptica de proyección en el ultravioleta profundo, destinado al Instituto de Microelectrónica de Barcelona de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Poland – Laboratory, optical and precision equipments (excl. glasses) – 76.2026 Dostawa sprzętu laboratoryjnego na potrzeby jednostek organizacyjnych Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu
France – Market and economic research; polling and statistics – Appel d'offres relatif à des prestations de service sur l'écoute des usagers et collectivités desservies par le service public de l'eau
France – Telephone network maintenance services – Maintenance préventive et corrective des autocommutateurs téléphoniques privés
Hungary – Electrical supplies and accessories – Szabadvezetéki szerelvények II. 2026 - Démász
Estonia – Consultative engineering and construction services – Põhjamaade-Balti vesinikukoridori ja selle toimimiseks vajaliku taristu riigi eriplaneeringu koostamine Majandus- ja Kommunikatsiooniministeeriumile
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
50 / 100
Risk factors
The large value attracts strong competition, potentially from major pharmaceutical suppliers.
Requirement for multiple certifications (quality, environmental) may be burdensome for smaller entities.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications